Market LIVE
Published markets; coverage varies by country
Product profile · United States

VAFSEO

 ·  Patent Litigation & Settlement History ↓

IngredientVADADUSTAT
Application typeNDA
Application215192
Product001
Dosage formTABLET
RouteORAL
Strength150MG
Approval date2024-03-27
Marketing statusPrescription
Status event—
ApplicantAKEBIA
Product source

Current GenericRadar decision

Year2034
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeDS_EQUIVALENT_PATENT
Anchor date2034-06-09
Patent anchor2034-06-09
Exclusivity anchor2029-03-27
Protection date2036-03-31
First Final ANDA—
Status event—

US11857543 c1 CKD anemia/daily doses covers dialysis label. Later crystal/formulation tails.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
85982102027-06-26DS/DP —YNTRUE_DS
English description not available.
———
85982102027-06-26ORANGE_BOOK —YNTRUE_DS
English description not available.
———
89407732027-06-26U U-3876NYU
English description not available.
———
89407732027-06-26ORANGE_BOOK U-3876NYU
English description not available.
———
RE474372027-06-26DS/DP —YNTRUE_DS
English description not available.
———
RE474372027-06-26ORANGE_BOOK —YNTRUE_DS
English description not available.
———
83439522027-08-14DS/DP —YNTRUE_DS
English description not available.
———
83439522027-08-14ORANGE_BOOK —YNTRUE_DS
English description not available.
———
78115952028-03-13DS/DP —YNTRUE_DS
English description not available.
———
78115952028-03-13ORANGE_BOOK —YNTRUE_DS
English description not available.
———
83236712028-04-03U U-3876NYU
English description not available.
———
83236712028-04-03ORANGE_BOOK U-3876NYU
English description not available.
———
125694742034-06-04U U-3876NYU
English description not available.
———
125694742034-06-04ORANGE_BOOK U-3876NYU
English description not available.
———
118575432034-06-09U U-3876NYU
English description not available.
———
118575432034-06-09ORANGE_BOOK U-3876NYU
English description not available.
———
101498422034-11-14DS/DP —NNDP
English description not available.
———
101498422034-11-14ORANGE_BOOK —NNDP
English description not available.
———
110652372034-11-14DS/DP/U U-3876NNDP
English description not available.
———
110652372034-11-14ORANGE_BOOK U-3876NNDP
English description not available.
———
97016362034-11-14DS/DP —NNDP
English description not available.
———
97016362034-11-14ORANGE_BOOK —NNDP
English description not available.
———
99872622034-11-14U U-3876NNU
English description not available.
———
99872622034-11-14ORANGE_BOOK U-3876NNU
English description not available.
———
113247342036-03-31DP —NNDP
English description not available.
———
113247342036-03-31ORANGE_BOOK —NNDP
English description not available.
———
118447562036-03-31U U-3876NNU
English description not available.
———
118447562036-03-31ORANGE_BOOK U-3876NNU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2024-03-272029-03-27English description not available.YY2029-03-27—Source
NCE2024-03-272029-03-27English description not available.YY2029-03-27
NCE
Full coverage date: 2029-03-27
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (1)
TypeDateRoleBasisSource
ANNUAL_DECISION_RECHECK—ANCHOR_AND_TAILUS11857543 c1 CKD anemia/daily doses covers dialysis label. Later crystal/formulation tails.Source
Decision history
CurrentYearStatusReviewAnchorJudged
Y2034DEEP_REVIEWFINAL2034-06-092026-10-17 20:32:21
N2034DEEP_REVIEWFINAL2034-06-092026-10-15 05:56:56
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.